Ambu

Ballerup, Denmark All Denmark companies → — Founded 1937

Healthcare Conglomerate Medical Device / Hardware Point-of-Care Diagnostics

Gastroenterology General Surgery

Gastroenterology AI Surgical AI

Public (listed on NASDAQ OMX Copenhagen) — Undisclosed (raised $161M from 1 Post IPO round on March 24, 2023)

Website Claim this company

Products

aScope Gastro

Ambu

Gastroenterology AI

The Ambu aScope Gastro is a sterile, single-use gastroscope with advanced imaging and design features for a variety of endoscopic procedures in the upper GI tract, offering portability and eliminating reprocessing.

Contact for pricing

See all 1 product →

About Ambu

Ambu is a global MedTech company that has been innovating healthcare solutions for over 85 years, with a strong focus on single-use medical devices. The company’s mission is to improve patient care through practical innovation, patient safety, and workflow efficiency. Ambu is particularly recognized for its pioneering work in single-use endoscopy, offering a comprehensive portfolio across pulmonology, urology, ear-nose-throat (ENT), and gastroenterology (GI).

For physicians, Ambu’s single-use endoscopes operate on an intuitive endoscopy systems platform, providing an interconnected solution set-up across various therapy areas. This approach aims to optimize workflow efficiency, enhance patient safety by reducing cross-contamination risks, and deliver consistent performance. Beyond endoscopy, Ambu also provides solutions in anesthesia and patient monitoring, including ventilation products and electrodes. The company’s commitment to innovation is further demonstrated by its investment in digital solutions, including AI and data insights, to enhance diagnostic accuracy, reduce variability, and expedite clinical decisions.

Ambu’s legacy includes the invention of the world’s first self-inflating resuscitator in 1956, known as the “Ambu bag,” which remains a global standard for emergency respiratory support. The company’s current strategy, “ZOOM AHEAD,” aims to achieve global endoscopy leadership by focusing on customer-centricity, innovation, building a scalable business platform, and fostering a culture of empowerment and growth.

Focus Areas

single-use endoscopy anesthesia patient monitoring pulmonology urology ear-nose-throat (ENT) gastroenterology airway management diagnostic equipment life-supporting equipment

Business Intelligence

Key Investors	Chr. Augustinus Factories
Partnerships	Atos (IT infrastructure services), Zerintia HealthTech (4RemoteHealth solution for remote support and training), Coloplast (visualization product for urology market)
Acquisitions	Medicotest (2001), King Systems (2013), Invendo Medical (2017)
Technology	EndoIntelligence™ (digital platform, previously Digital Solutions & Systems), Ambu endoscopy platform (smart display devices with HD technology, dual-view capabilities, intuitive interface, multi-display connectivity, seamless integration with PACS and EHR)
FDA Clearances	unknown cleared products (estimated)

What Physicians Need to Know

Single-Use Endoscopy

Ambu is a leader in single-use endoscopy, offering a comprehensive portfolio across various medical specialties. Their single-use endoscopes eliminate the need for reprocessing, reducing the risk of cross-contamination and improving patient safety. This approach also streamlines workflow, ensuring scopes are always available and reducing procedure delays. Ambu's single-use endoscopes are designed for consistent high quality and performance, as they are new for each patient.

Anesthesia & Airway Management

Ambu is renowned for its innovations in anesthesia and airway management, including the original Ambu Bag, the world's first self-inflating resuscitator. Their product range includes disposable laryngeal masks (AuraGain, AuraOnce, AuraFlex, AuraStraight), video laryngoscopes (Ambuu00ae SureSightu2122 Connect, Ambuu00ae SureSightu00ae Mobile), and double lumen tubes with integrated cameras (Ambuu00ae VivaSightu2122 2 DLT) for one-lung ventilation. These solutions aim to save lives, improve patient care, and simplify workflow for anesthesiologists and airway management professionals.

Patient Monitoring & Diagnostics

Ambu provides diagnostic and life-supporting equipment, with a focus on patient monitoring. This includes a range of electrodes for ECG tests and neurophysiological mappings. Their products are designed to be technologically advanced, user-friendly, and effective in improving patient outcomes.

Pulmonology

Ambu offers single-use bronchoscopes, building on over a decade of expertise in this area. Their aScope Broncho solutions provide reliable, sterile, and cost-effective options for a wide range of procedures, from intubations and secretion management to advanced diagnostic and therapeutic bronchoscopies. The aScope 5 Broncho offers high performance and flexibility for complex workflows, while the aScope 4 Broncho is designed for essential procedures.

Urology

Ambu's urology portfolio includes a complete suite of single-use endoscopes such as the aScope 5 Uretero, aScope 5 Cysto HD, and aScope 4 Cysto. These devices offer exceptional imaging quality, including advanced red contrast (ARC) technology in the aScope 5 Cysto HD, for precise anatomy checks and faster diagnoses. Single-use solutions in urology enhance efficiency, reduce wait times, and minimize the risk of cross-contamination.

Ear-Nose-Throat (ENT)

Ambu's ENT endoscope solutions, such as the aScope 4 RhinoLaryngo, are designed for portability, immediate availability, and ease of use in flexible rhinolaryngoscopy procedures. These single-use scopes eliminate reprocessing and repair needs, allowing for quicker response times to airway emergencies and improved patient care.

Gastroenterology

Ambu's single-use GI endoscope solutions, including the aScope Gastro, aScope Gastro Large, and aScope Duodeno 2, offer the benefits of conventional endoscopes with added efficiency and sterility. These gastroscopes are particularly suited for high-risk, intraoperative, and critical care GI endoscopy settings, providing consistent performance and reducing the risk of cross-contamination. The aScope Gastro Large is notable for being the first endoscope with a bioplastic handle, contributing to environmental sustainability.

Physician Tip

Ambu's single-use philosophy is a game-changer for physicians. Expect immediate availability of sterile equipment, eliminating delays from reprocessing or repairs, and ensuring consistent, like-new performance for every procedure. This translates to improved workflow efficiency, allowing you to focus more on patient care and less on equipment logistics. The enhanced visualization, particularly with features like dual-view video laryngoscopy and HD imaging in urology, can lead to more precise diagnoses and improved patient outcomes. Furthermore, the integrated video and image capture capabilities in many of their endoscopy systems facilitate documentation, collaboration, and training.

Ambu's endoscopy systems, such as the aViewu2122 2 Advance and aBoxu2122 2, offer plug-and-play compatibility with their range of single-use endoscopes. These systems provide full-HD imaging, intuitive user interfaces, and features like WorkList for effortless patient data import and export, fully integrated with EHR systems. Enhanced cybersecurity with WPA2 and WPA3 compliance is also a key feature for secure Wi-Fi connectivity. The SureSight Video Laryngoscope integrates seamlessly with Ambu's single-use bronchoscopy platform, offering a comprehensive airway visualization ecosystem.

At a glance

Founded 1937

HQ Ballerup, Denmark · Denmark

Team size 5,631 (as of March 2026)

CEO Britt Meelby Jensen

Funding Public (listed on NASDAQ OMX Copenhagen) — Undisclosed (raised $161M from 1 Post IPO round on March 24, 2023)

FDA clearances unknown (estimated)

Products 1

Visit site

Products by Ambu

1 product in the directory

aScope Gastro

Ambu

Gastroenterology AI

Contact for pricing

What the Web Says

Ambu is a medical device company with a long history, generally well-regarded for its innovative single-use endoscopy products, particularly in the pulmonology and ENT fields. Employer reviews suggest a company with a strong mission and good work-life balance in some departments, but also highlight challenges with management, internal communication, and career progression.

Overall: Mixed

Strengths

Innovative single-use medical devices (e.g., endoscopes)
Strong market position in specific medical device niches
Positive impact on patient safety (single-use products)
Good work-life balance reported by some employees
Strong company mission and values
Collaborative environment in certain teams

Limitations

Inconsistent management quality across departments
Challenges with internal communication and transparency
Limited opportunities for career advancement for some roles
Bureaucratic processes can hinder agility
Compensation may not be competitive in all areas
High workload reported in some departments

Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT Reviewers (general sentiment)

Last updated: 2026-08-08

Videos

News, demos, and interviews about Ambu.

Loading videos...

Videos load interactively. If none appear, search YouTube for Ambu →

View all on YouTube

Press & Coverage

Urology Times

FDA grants 510(k) clearance to Ambu's single-use ureteroscope

Ambu's single-use ureteroscopy solution, consisting of the aScope 5 Uretero and aBox 2 endoscopy system, has received 510(k) clearance from the FDA. This solution was also granted CE mark in Europe in November 2023 and is notable for being the first ureteroscope made with bioplastics.

2024-07

PubMed (Otolaryngologyu2013Head and Neck Surgery)

Complications Associated with AMBUu2122 Scope Use: An FDA MAUDE Analysis

An analysis of the FDA MAUDE database from 2000 to 2023 identified 30 unique adverse events associated with Ambuu00ae aScopeu2122 use, with 21 related to patient injury and 9 to device malfunction. The study concludes that while Ambuu00ae aScopeu2122 flexible nasolaryngoscopes and bronchoscopes are effective, they may infrequently act as foreign bodies with potentially life-threatening consequences.

2024-07

Ambu

Ambu obtains European regulatory clearance of its complete fifth-generation bronchoscope portfolio

Ambu announced European regulatory clearance (CE mark) for two new smaller sizes of its fifth-generation bronchoscope, the Ambuu00ae aScopeu2122 5 Broncho, completing its portfolio for various patient needs in bronchoscopy. This extends Ambu's market leadership in pulmonology.

2023-11

Ambu

CMS Grants Transitional Pass-Through (TPT) Payment for Ambu's aScope 5 Broncho HD Single-Use Bronchoscope

Ambu Inc. announced that the Centers for Medicare & Medicaid Services (CMS) granted transitional pass-through (TPT) payment for its aScope 5 Broncho HD, effective January 1, 2024. This payment facilitates Medicare beneficiary access to the benefits of this new and innovative single-use bronchoscope.

2023-12

Ambu

Ambu Receives FDA Clearance of Two Smaller Sizes of its Fifth-Generation Bronchoscope, the aScopeu2122 5 Broncho

Ambu Inc. received FDA clearance for two smaller sizes of its fifth-generation bronchoscope, the Ambuu00ae aScopeu2122 5 Broncho. The 2.7mm size is the first ultra-thin single-use bronchoscope with a working channel available in the U.S., improving imaging, networking, documentation, and audio features.

2023-08

Ambu

Ambu Announces FDA Clearance of First-Generation Single-Use Colonoscope

Ambu announced 510(k) regulatory clearance from the U.S. FDA for its single-use colonoscope solution, the Ambuu00ae aScopeu2122 Colon and the Ambuu00ae aBoxu2122 2 endoscopy system. This expands Ambu's gastroenterology offering with single-use efficiency for interventional and diagnostic procedures.

2023-09

PubMed Central (Advances in Therapy)

Systematic Review and Cost-Consequence Analysis of Ambu aScope 5 Broncho Compared with Reusable Flexible Bronchoscopes: Insights from Two US University Hospitals and an Academic Institution

This systematic review and cost-consequence analysis compared the Ambu aScopeu2122 5 Broncho with reusable flexible bronchoscopes in high-volume U.S. hospitals. The study aimed to assess incremental cost and cross-infection risk, finding that reusable bronchoscopes were cost-minimizing in high-volume settings.

2023-05

Ambu USA Insights Blog

Ambu Scores High for Safety and Versatility in New Study

A recent study from Cork University in Ireland found the Ambu aScopeu2122 5 bronchoscope to be safe and versatile with high user satisfaction in 98 procedures. Clinicians used the endoscope without complications or the need to switch to a reusable scope.

2025-02

Frequently Asked Questions

What single-use endoscopy solutions does Ambu offer, and how do they compare to reusable scopes in terms of infection control and workflow efficiency?

Ambu offers a comprehensive portfolio of single-use endoscopes across various specialties, including pulmonology (bronchoscopes), urology (cystoscopes), ENT (rhinolaryngoscopes), and gastroenterology (duodenoscopes, colonoscopes, gastroscopes). These devices aim to eliminate the risk of cross-contamination inherent with reusable scopes, streamline workflow by removing reprocessing steps, and ensure immediate availability for procedures.

How does Ambu ensure the quality and compliance of its single-use devices with relevant healthcare regulations and standards?

Ambu adheres to stringent quality management systems and regulatory requirements, including FDA regulations and ISO standards, for all its single-use devices. Each product undergoes rigorous testing and validation to ensure patient safety, efficacy, and consistent performance, with a focus on sterile packaging and manufacturing processes.

Can you elaborate on Ambu's offerings in anesthesia and airway management, particularly regarding products that enhance patient safety and procedural success?

Ambu provides a range of solutions for anesthesia and airway management, including resuscitators, laryngeal masks, and aScopeu2122 single-use bronchoscopes for intubation and airway visualization. These products are designed to facilitate efficient and safe airway management, reduce the risk of complications, and support clinicians in critical care settings.

What kind of support and training does Ambu provide to healthcare professionals for integrating their single-use endoscopy and patient monitoring solutions?

Ambu offers comprehensive support and training programs for healthcare professionals, including on-site product demonstrations, clinical education, and technical support. Their goal is to ensure seamless integration of their single-use endoscopy and patient monitoring solutions into existing clinical workflows, optimizing user proficiency and patient outcomes.

What is Ambu's strategy for pricing its single-use devices, and what are the potential cost-benefit advantages for healthcare institutions compared to traditional reusable equipment?

Ambu's pricing strategy for single-use devices considers the total cost of ownership, including the elimination of reprocessing costs, reduced capital expenditure on sterilization equipment, and minimized risk of hospital-acquired infections. The aim is to offer a cost-effective solution that enhances patient safety and operational efficiency, providing a strong return on investment for healthcare institutions.

How does Ambu address the environmental impact of its single-use products, and what initiatives are in place for sustainability?

Ambu acknowledges the environmental impact of single-use devices and is actively working on sustainability initiatives. This includes exploring more environmentally friendly materials, optimizing packaging, and investigating recycling programs where feasible, aiming to balance patient safety with environmental responsibility.

Related Companies

Suggest an Edit →